FDA Approved: SUNLENCA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sunlenca (lenacapavir sodium) from Gilead Sciences. This action approves a supplemental NDA for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SUNLENCA (LENACAPAVIR SODIUM)

Snippet

SUPPL AP for SUNLENCA (LENACAPAVIR SODIUM)